References
- DaviesHBignellGRCoxCMutations of the BRAF gene in human cancerNature2002417689294995412068308
- DhomenNMaraisRNew insight into BRAF mutations in cancerCurr Opin Genet Dev2007171313917208430
- TiacciESchiavoniGForconiFSimple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutationBlood2012119119219522028477
- XiLAronsENavarroWBoth variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutationBlood2012119143330333222210875
- HeaneyMLGoldeDWMyelodysplasiaN Engl J Med1999340211649166010341278
- XingMAlzahraniASCarsonKAAssociation between BRAF V600E mutation and mortality in patients with papillary thyroid cancerJAMA2013309141493150123571588
- GrishamRNIyerGGargKBRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancerCancer2013119354855422930283
- MarchettiAFelicioniLMalatestaSClinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutationsJ Clin Oncol201129263574357921825258
- ChesiMBergsagelPLMolecular pathogenesis of multiple myeloma: basic and clinical updatesInt J Hematol201397331332323456262
- RothADTejparSDelorenziMPrognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trialJ Clin Oncol201028346647420008640
- ChapmanPBHauschildARobertCImproved survival with vemurafenib in melanoma with BRAF V600E mutationN Engl J Med2011364262507251621639808
- HauschildAGrobJ-JDemidovLVDabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trialLancet2012380983935836522735384
- HymanDMPuzanovISubbiahVVemurafenib in multiple nonmelanoma cancers with BRAF V600 mutationsN Engl J Med2015373872673626287849
- AsciertoPAKirkwoodJMGrobJ-JThe role of BRAF V600 mutation in melanomaJ Transl Med2012108522554099
- SteinbrunnTStühmerTGattenlöhnerSMutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survivalBlood201111761998200421149634
- ChoN-YChoiMKimB-HChoY-MMoonKCKangGHBRAF and KRAS mutations in prostatic adenocarcinomaInt J Cancer200611981858186216721785
- ShenYLuYYinXZhuGZhuJKRAS and BRAF mutations in prostate carcinomas of Chinese patientsCancer Genet Cytogenet20101981353920303012
- RenGLiuXMaoXIdentification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancerGenes Chromosomes Cancer201251111014102322833462
- LiuTWillmore-PayneCLayfieldLJHoldenJALack of BRAF activating mutations in prostate adenocarcinoma: a study of 93 casesAppl Immunohistochem Mol Morphol200917212112518987552
- KöllermannJAlbrechtHSchlommTActivating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patientsOncol Lett20101472973222966370